Kathryn has had the opportunity to contribute in a wide range of leadership positions in public and private companies, government bodies and non-profit organizations. Her current portfolio: Chair – Luminesce Alliance, a consortium of Cancer Research and Treatment centers for Children with Sydney Children’s Hospitals Network, University of Sydney and University of NSW. Chair – Pennington Institute, Australia’s pre-eminent harm minimization for Drugs education program. Chair – Ministerial Advisory Council on Ageing (MACA), providing advice on issues and concerns of older NSW citizens to the NSW Government. Chair – Lifestart Co-op Ltd, a Disability support service. Director – Paul Ramsay Foundation Board. Director – Relationships Australia (NSW). Kathryn has also participated in or led Inquiries into Education: the Gonski Review and NSW Catholic Funding Review and led the Review into Retirement Villages in NSW. Her corporate board experience has been in media, financial services and services provision. Her professional history has been in Social Work and Early Childhood Services as well as media roles at Radio 2UE and Channel 10. From 1995-2004 Kathryn was an elected Councillor to the Sydney City Council. She is the recipient of an Order of Australia (AO). Kathryn holds a Bachelor of Social Work (UNSW), Certificate in Early Childhood (Macquarie University) and was awarded a Doctor of Letters (Honoris Causa) from UNSW.

BSc (Psych) (Hons), PhD, Hon DSc (UNSW), FAHMS. Michelle has dedicated her entire professional life to improving clinical outcomes for children with cancer. She is one of Australia’s leading translational researchers and is world-renowned for her research into the childhood cancers neuroblastoma and leukaemia. She is Executive Director of Children’s Cancer Institute, an organisation she joined as a staff scientist in 1984, and is known for her world-class research into the treatment of neuroblastoma and acute lymphoblastic leukaemia in children. Michelle also leads ZERO Childhood Cancer — the most comprehensive precision medicine program for children and young people with cancer in the world. She holds a conjoint appointment as Professor in the Faculty of Medicine at the University of New South Wales in Sydney, Australia, and was awarded an Honorary Doctorate from the University of New South Wales for her eminent service to the cancer research community in 2008. She is passionate about translational medical research and was appointed a Member of the Order of Australia for services to science in the field of research into childhood cancer, to scientific education and to the community in 2007. In 2014, she was awarded the Cancer Institute NSW’s Premier’s Award for Outstanding Cancer Researcher of the Year, and in 2015 she was appointed an Inaugural Fellow of the Australian Academy of Health and Medical Sciences and a Fellow of the Australian Academy of Science in 2022.

BSc (Med) MBBS PhD FRACP FAAHMS FAA. Roger has a long and distinguished career in oncology and medical research, including establishing the Cancer Research Unit at the Children’s Medical Research Institute (CMRI) more than 30 years ago, which he continues to lead. He has been the executive director of CMRI and the Sir Lorimer Dods Professor, at Sydney Medical School, University of Sydney, since 2007. Roger’s research focus is the immortality of cancer cells, an almost universal characteristic of cancers, with a particular focus on the role of chromosome ends (telomeres). The main aim of this work is to find new cancer treatments, but it is also contributing to understanding premature ageing in children and ageing in adults. With a keen interest in precision cancer medicine, big data and creating high-performing teams, Roger values the opportunities created by Luminesce Alliance for researchers to align their efforts for the benefit of children and their families. Roger has extensive experience of serving on medical advisory panels and has been elected a Fellow of the Australian Academy of Science and of the Australian Academy of Health and Medical Sciences. He has been awarded the Ramaciotti Medal for Excellence in Biomedical Research, the NSW Premier’s Award for Outstanding Cancer Researcher of the Year, and the Neil Hamilton Fairley Medal of the Royal Australasian College of Physicians. In 2021, he was awarded an Order of Australia. Directorships: Executive Director – Children’s Medical Research Institute (CMRI); Member of Board of Directors – Garvan Institute of Medical Research.

Cathryn Cox PSM was appointed Chief Executive of Sydney Children’s Hospitals Network in August 2020. Cathryn has many years of experience as an Executive within NSW Health with responsibility for a range of health policy, planning, infrastructure and strategic reform programs. Cathryn is passionate about the role of Sydney Children’s Hospitals Network in providing world-class patient-centred care for children and young people, and their families, as well as ground breaking health research and its translation into clinical practice. Cathryn is a member of a number of Boards and is an Adjunct Associate Professor at the University of Sydney. Cathryn was awarded a Public Service Medal in 2018. Directorships: Director – Sydney Health Partners; Director – Maridulu Budyari Gumal, the Sydney Partnership for Health, Education, Research and Enterprise (SPHERE); Director – NSW Health Pathology Board; Chair – National Centre for Immunisation Research and Surveillance Advisory Board.